New direction for epilepsy treatment

	Tweet

If common anticonvulsant drugs fail to manage epileptic seizures, then perhaps the anti-inflammatory* route is the way to go. That’s according to Mattia Maroso and colleagues from the Mario Negri Institute for Pharmacological Research in Milan, Italy, who found that giving mice repeated doses of a specific enzyme inhibitor significantly reduced both chronic epileptic activity and acute seizures. Their findings, published online in the Springer journal Neurotherapeutics, open up the possibility of a new target system for anticonvulsant drug intervention, to control epileptic activity that does not respond to certain anticonvulsant treatments.

An enzyme known as ICE/Caspase-1 is involved in epileptic seizures; it induces inflammatory processes by producing IL-1beta, a pro-inflammatory molecule, in brain regions where epileptic activity originates and spreads. Mattia Maroso and colleagues looked at the elective inhibitor for this enzyme, in a mouse model of acute seizures and in mice with chronic epilepsy showing spontaneous recurrent epileptic activity.

The researchers artificially induced chronic epileptic seizures in 21 adult male mice and acute seizures in 46 mice. They then injected them with the enzyme inhibitor (VX-765) and recorded the resulting epileptic activity in brains of the mice.

They found that the enzyme inhibitor had powerful anticonvulsant effects. Repeated systemic administration reduced chronic epileptic activity in mice in a dose-dependent manner, and the effect was reversible after four days of treatment when the drug regime was discontinued. The same dose regimen also reduced acute seizures in the mice.

The authors conclude: “Our results support a new target system for anticonvulsant drug intervention. Our findings open new perspectives for the clinical use of this anti-inflammatory strategy for treating established drug-resistant epileptic conditions.”

* Brain inflammation is an important factor in human epilepsy.

Reference
Maroso M et al (2011). Interleukin-1β Biosynthesis Inhibition Reduces Acute Seizures and
Drug Resistant Chronic Epileptic Activity in Mice. Neurotherapeutics DOI 10.1007/s13311-011-0039-z

###

Joan Robinson
Springer Science

RELATED STORIES:
Newly discovered role for enzyme in neurodegenerative diseases   Surgery, exercise may offer Parkinson’s hope   Dog epilepsy gene discovery could aid people - study   Dispelling myths about Alzheimer’s disease   Mouse gene suppresses Alzheimer’s plaques and tangles   Non-epileptic seizures may be misdiagnosed longer in veterans   Vitamin B12 tied to Alzheimer’s   Gene variations affect stroke risk after surgery   Have we met before?   A more ethical way to compare epilepsy treatments   Vitamin E may ward off Lou Gehrig’s disease   New guidelines for diagnosis and treatment of Parkinson disease

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.